Context Therapeutics Inc
CNTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$21.99M
Close$
$0.69
189.3% upside
Current Fair Value
189.3% upsideUndervalued by 189.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $21.99 Million |
|---|---|
| Enterprise Value | $-20,758,692.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.38 |
| Beta | 1.72 |
| Outstanding Shares | 95,183,718 |
Return
| Return on Equity | -120.40% |
|---|---|
| Return on Assets | -99.62% |
| Return on Invested Capital | -126.32% |
Valuation & Multiples
| P/E Ratio | -0.5 |
|---|---|
| PEG | -0.77 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.43 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 203.26% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 66.23%▼ 14.61% |
|---|---|
| Total Invested | $34.92M▼ 82.06% |
| Investors Holding | 81▲ 19.00% |
ESG Score
No data